Meropenem
Lynda R. Wiseman, Antona J. Wagstaff, Rex N. Brogden et al. · Drugs · 1995
Cited by 209 works. doi:10.2165/00003495-199550010-00007
Authors
References
- Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases
- Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin
- Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa
- Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem
- Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa
- Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins
- Decreased susceptibility of penicillin-resistant pnenmococci to twenty-four βlactam antibiotics
- Extended-spectrum plasmid-mediated -lactamases
- In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I